Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lung carcinoma cell type unspecified recurrent
ADR ID BADD_A07371
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.02      Respiratory tract and pleural neoplasms malignant cell type unspecified NEC
16.19.02.005      Lung carcinoma cell type unspecified recurrent
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.018      Lung carcinoma cell type unspecified recurrent
Description Not Available
MedDRA Code 10025065
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bronchial carcinoma recurrent | Cancer of bronchus recurrent | Cancer of lung recurrent | Carcinoma bronchiogenic recurrent | Lung cancer recurrent | Lung carcinoma cell type unspecified recurrent | Lung carcinoma recurrent | Malignant neoplasm of bronchus and lung recurrent | Malignant neoplasm of lower lobe, bronchus or lung, recurrent | Malignant neoplasm of main bronchus recurrent | Malignant neoplasm of middle lobe, bronchus or lung, recurrent | Malignant neoplasm of other parts of bronchus or lung, recurrent | Malignant neoplasm of trachea, bronchus, and lung, recurrent | Malignant neoplasm of upper lobe, bronchus or lung, recurrent | Pulmonary carcinoma cell type unspecified recurrent | Pulmonary carcinoma recurrent
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00511Clozapine0.001834%
BADD_D00800Erlotinib0.000168%
BADD_D01008Gefitinib0.000280%
BADD_D02236Tofacitinib0.000241%
BADD_D02392Zoledronic acid--
BADD_D02509Brigatinib0.000224%
BADD_D02586Radium ra-223 dichloride-
The 1th Page    1    Total 1 Pages